Presenting on the surface of cancer cells and not healthy cells in vivo, cell surface HSPA5 is an exciting target for antibody therapeutics, thereby providing valuable insights into the clinical values of HSPA5 antibodies for the prognosis and therapy of cancer and as anti-SARS-CoV-2 (12). Here, HSPA5 is linked to cancer.